TP53 and acute myeloid leukemia: TP53 mutations are associated with complex karyotypes, transformation to AML, and adverse outcomes [31], which especially applies to MDS with multiple TP53 hits, since monoallelic patients showed no difference from TP53 wild‐type patients in outcomes in the analysis of the TP53 allelic state [32].